Company page

Genfleet Therapeutics (shanghai), Inc. Class H

Genfleet Therapeutics (Shanghai), Inc. Class H, trading under the ticker 2595 on the Hong Kong market, has a market capitalization of approximately HKD 1.56 billion. The company focuses on developing innovative therapies in the biotechnology sector. Its strategic initiatives aim to address unmet medical needs and enhance patient outcomes.